LULU - Ultrathink: A Buffett/Munger Meditation

"Price is what you pay. Value is what you get." - Warren Buffett

The Core Question: Is Lululemon's Best Chapter Behind It?

Wall Street has made up its mind. Down 68% from the highs. Twelve times earnings for a company that still generates 32% return on equity and holds $1.8 billion in cash with zero financial debt. The market is saying, clearly and loudly: this is a broken company.

But is it?

Let me think about this the way Charlie Munger would -- by inversion. What would have to be true for Lululemon to be worth only $162 per share, or even less? You would need to believe that the North American consumer has permanently rejected the brand. That China's torrid growth is a mirage. That no CEO, however talented, can revive the product engine. That tariffs will permanently crush margins. And that 25 years of brand equity can evaporate in 18 months.

I do not believe all of those things simultaneously. And therein lies the opportunity.

The Moat Meditation: What Lululemon Actually Sells

Lululemon does not sell yoga pants. It sells identity.

When a woman walks into a Lululemon store, she is not making a rational textile-purchasing decision. She is buying membership in a tribe -- the community of women (and increasingly men) who signal health, ambition, and taste through their athletic wear. The $128 Align legging is not 40% better than a $78 Nike equivalent in terms of fabric technology. It is 40% better as a social signal.

This is why the brand has survived sheer-pants scandals, founder embarrassments, and now a CEO departure. The community persists because it is organic, rooted in local ambassador relationships and in-store experiences that no competitor has successfully replicated at scale. Vuori and Alo Yoga are real threats, but they remain niche -- combined, they are perhaps one-tenth of Lululemon's scale.

The DTC model -- 93% direct sales -- is the structural moat within the moat. Nike generates 45% through wholesale. Ralph Lauren even less. When you own your customer relationship, you own the data, the pricing, and the experience. Lululemon's 20% operating margin versus the industry's 10-12% is not an accident. It is the mathematical expression of vertical integration done right.

But moats do not stay wide by themselves. They require reinvestment and vigilance. And here is where the concern lies.

The Honest Worry: North America Is Not Fine

Management's admission that core franchises -- Scuba, Dance Studio, Softstream -- had become "stale" was a rare moment of corporate honesty. In apparel, staleness is death by a thousand small cuts. Customers do not announce they are leaving. They simply buy their next pair somewhere else.

North America declined 1% in FY2026. Q4 was down 4%. Management is guiding -1% to -3% for FY2027. These numbers, for a company that grew U.S. revenue at 20%+ for years, represent a genuine inflection point. The question is whether this is a J-curve -- a temporary dip before product refresh drives recovery -- or the beginning of the long plateau that Gap experienced in the early 2000s.

I lean toward the former, but I assign meaningful probability to the latter. The 35% product newness target for Spring 2026 is encouraging. But talking about newness and executing newness are different things. We will not know until we see Q2 and Q3 FY2027 comp data.

The inventory situation is a secondary concern. Inventory up 18% in dollars but only 6% in units. The dollar increase reflects higher input costs (tariffs) and inventory positioning for new international stores. This is not the same as inventory accumulation from slowing demand -- yet. But it bears monitoring. If inventory grows faster than revenue for another two quarters, the discounting spiral risk becomes real.

China: The Second Act

China is doing something remarkable. Revenue grew 28% in Q4, with comps up 26%. For FY2027, management guides about 20% growth. In a market where Lululemon competes against local brands, Li-Ning, and international giants, this sustained growth is evidence of genuine brand resonance.

China now represents roughly 18% of global revenue and is on track to exceed 20% within two years. This transforms the investment thesis. Lululemon is not just a North American athletic brand with a China experiment. It is becoming a global premium lifestyle brand with China as a genuine second pillar.

But China concentration brings China risk. Anti-Western sentiment, regulatory unpredictability, consumer confidence swings, and geopolitical tensions are all real. Lululemon's Canadian identity provides some insulation -- Beijing has less reason to target Vancouver than Beaverton or Cupertino -- but any Western consumer brand in China operates at the pleasure of forces beyond its control.

The expansion into six new international markets in 2026, including Mexico, Greece, and Poland, shows management is not over-indexing on China. This geographic diversification is exactly what a prudent capital allocator should do.

The CEO Question: Will Heidi O'Neill Be the Right Leader?

The announcement of Heidi O'Neill on April 22 is the most significant development since the analysis began. Twenty-seven years at Nike, most recently as President of Consumer, Product & Brand -- directly overseeing the integration of men's, women's, and kids' consumer teams, the global product engine, and brand marketing.

This is a strong hire on paper. But paper and reality diverge. The critical question is whether O'Neill can adapt from Nike's wholesale-heavy, celebrity-endorsement culture to Lululemon's DTC, community-driven, grassroots model. Nike's approach to brand building is fundamentally different -- top-down, media-driven, athlete-centric. Lululemon's is bottom-up, community-driven, ambassador-centric.

The best case: O'Neill brings Nike's product innovation discipline and global scaling expertise while preserving Lululemon's community DNA. She brings rigor without destroying soul.

The worst case: She imports Nike's bloated corporate culture, over-emphasizes wholesale expansion, and alienates the educator community that is Lululemon's secret weapon.

I give the best case higher probability than the worst, primarily because the board appears to have conducted a thorough search and understands the cultural risk. But we will not know for certain until 12-18 months into her tenure.

The Valuation Philosophy: What Are You Really Paying?

At $162.60 per share, you are paying:

• 12.3x trailing earnings
• 10.4x owner earnings
• 7.1x EBITDA
• A 5% FCF yield

For context, the average P/E for Lululemon over the past decade has been approximately 30x. The stock has traded below 15x exactly once before -- briefly during the March 2020 COVID crash, before snapping back 300%.

Nike -- a slower-growing company with lower margins, higher debt, and declining revenue -- trades at 22x earnings. Ralph Lauren, with inferior margins and growth, commands 18x.

Either the market is telling you that Lululemon's quality has permanently degraded to the level of a mediocre apparel retailer, or it is presenting a mispricing caused by the confluence of multiple temporary headwinds arriving simultaneously.

I believe it is the latter. The balance sheet ($1.8B cash, zero debt) provides a margin of safety that many investors overlook. This is not a leveraged turnaround where execution failure leads to financial distress. This is a cash-rich business temporarily earning less, with a stock price that discounts permanent impairment.

The Patient Investor's Path

The right way to own Lululemon at $162 is with patience, humility, and position-size discipline.

Position at 2-3% of portfolio. Not larger, because the North America recovery is unproven, the CEO does not start until September, and the consumer environment is genuinely uncertain. Not smaller, because the risk-reward at 12x earnings for a business with this quality profile is rare.

The accumulation zone is $135-$170. Below $135 -- should macro deterioration or proxy battle drama create another leg down -- increase to 4-5%. This would represent crisis pricing for a business generating nearly $1 billion in annual free cash flow.

The thesis resolves over 12-24 months. The first checkpoint is Q1 FY2027 results (late May/June 2026). North America comps will tell whether the product refresh is working. The second checkpoint is O'Neill's first strategic presentation, likely late 2026 or early 2027. The third is FY2027 full-year results (March 2027), where we will see whether the EPS trough was FY2027 or whether the decline continues.

If, after 18-24 months, North America comps remain negative, China growth decelerates below 10%, and gross margins have breached 50%, the thesis is wrong and the position should be exited. Knowing your exit criteria before you enter is the Munger discipline that separates investing from hoping.

Final Reflection

Lululemon at $162 reminds me of Starbucks at various points in its history -- a premium consumer brand with a powerful community, temporarily struggling with domestic saturation while international growth provides the runway for the next chapter. Starbucks always recovered because the brand was real. The community was real. The product experience was real.

The same is true of Lululemon. The brand is real. The community is real. The $128 Align legging experience is real. What is temporarily unreal is the stock price, which implies that none of this matters anymore.

I think it does. At 12x earnings with a fortress balance sheet, you are paying a trough price for an above-average business. Even if the recovery takes longer than expected, the downside is limited by the cash generation and buyback floor. And if recovery comes -- as I believe it will under new leadership -- the upside is 30-70%.

That is the kind of asymmetry that patient capital is designed to exploit.

"In the short run, the market is a voting machine. In the long run, it is a weighing machine." - Benjamin Graham